WO2002020018A8 - Tablets containing epinastine manufactured by direct compression - Google Patents

Tablets containing epinastine manufactured by direct compression

Info

Publication number
WO2002020018A8
WO2002020018A8 PCT/EP2001/010139 EP0110139W WO0220018A8 WO 2002020018 A8 WO2002020018 A8 WO 2002020018A8 EP 0110139 W EP0110139 W EP 0110139W WO 0220018 A8 WO0220018 A8 WO 0220018A8
Authority
WO
WIPO (PCT)
Prior art keywords
manufactured
direct compression
tablets containing
containing epinastine
epinastine
Prior art date
Application number
PCT/EP2001/010139
Other languages
French (fr)
Other versions
WO2002020018A1 (en
Inventor
Toshimitsu Ohki
Kazutoshi Yokoyama
Wakuko Yamaguchi
Original Assignee
Boehringer Ingelheim Int
Toshimitsu Ohki
Kazutoshi Yokoyama
Wakuko Yamaguchi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Toshimitsu Ohki, Kazutoshi Yokoyama, Wakuko Yamaguchi filed Critical Boehringer Ingelheim Int
Priority to BR0113731-0A priority Critical patent/BR0113731A/en
Priority to AU2001291820A priority patent/AU2001291820A1/en
Priority to MXPA03002013A priority patent/MXPA03002013A/en
Publication of WO2002020018A1 publication Critical patent/WO2002020018A1/en
Publication of WO2002020018A8 publication Critical patent/WO2002020018A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a tablet manufactured by a direct compression process comprising Epinastine as an active agent with an improved storage stability.
PCT/EP2001/010139 2000-09-08 2001-09-04 Tablets containing epinastine manufactured by direct compression WO2002020018A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BR0113731-0A BR0113731A (en) 2000-09-08 2001-09-04 Epinastine-containing tablets produced by direct compression
AU2001291820A AU2001291820A1 (en) 2000-09-08 2001-09-04 Tablets containing epinastine manufactured by direct compression
MXPA03002013A MXPA03002013A (en) 2000-09-08 2001-09-04 Tablets containing epinastine manufactured by direct compression.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000315849A JP2002087963A (en) 2000-09-08 2000-09-08 Epinastine-containing tablet produced by direct compression
JP2000-315849 2000-09-08

Publications (2)

Publication Number Publication Date
WO2002020018A1 WO2002020018A1 (en) 2002-03-14
WO2002020018A8 true WO2002020018A8 (en) 2002-09-19

Family

ID=18794888

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/010139 WO2002020018A1 (en) 2000-09-08 2001-09-04 Tablets containing epinastine manufactured by direct compression

Country Status (6)

Country Link
JP (1) JP2002087963A (en)
AU (1) AU2001291820A1 (en)
BR (1) BR0113731A (en)
EC (1) ECSP034501A (en)
MX (1) MXPA03002013A (en)
WO (1) WO2002020018A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494065A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5162141B2 (en) * 2007-02-20 2013-03-13 エスエス製薬株式会社 Film coating composition
JP5291324B2 (en) * 2007-11-01 2013-09-18 沢井製薬株式会社 Orally disintegrating tablets
JP5806490B2 (en) * 2011-03-31 2015-11-10 エスエス製薬株式会社 Film coating composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19542281C2 (en) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Use of Epinastin for the treatment of migraines
IL136461A0 (en) * 1997-12-23 2001-06-14 Schering Corp Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
EP1000623A1 (en) * 1998-09-29 2000-05-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Use of epinastine as antitussivum
JP4016128B2 (en) * 1999-09-09 2007-12-05 東和薬品株式会社 Light-resistant epinastine hydrochloride film-coated tablets

Also Published As

Publication number Publication date
WO2002020018A1 (en) 2002-03-14
MXPA03002013A (en) 2003-07-24
JP2002087963A (en) 2002-03-27
BR0113731A (en) 2003-07-29
AU2001291820A1 (en) 2002-03-22
ECSP034501A (en) 2003-04-25

Similar Documents

Publication Publication Date Title
MXPA02006826A (en) Cell division inhibitors and process for producing the same.
MXPA03002309A (en) Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds.
HK1072597A1 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
WO2005067887A3 (en) Formulations of ramipril
TWI319326B (en) Stable high -concentration injection containing 3-methyl-1-phenyl-2-pyrazolin-5-one
MXPA03004980A (en) Delta 1-pyrrolines used as pesticides.
IL164449A0 (en) Clear antiperspirant with alcohol free active
WO2001007049A3 (en) Ophthalmic composition comprising ketotifen
AU2001270922A1 (en) Accumulator
MY133322A (en) Storage stable tablets of fosinopril sodium
TNSN05330A1 (en) Tablet comprising fluvastatin and carmellose calcium
WO2003086362A3 (en) Method of stabilizing bupropion hydrochloride tablets
HUP0301072A3 (en) Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient
WO2002020018A8 (en) Tablets containing epinastine manufactured by direct compression
AU2001270156A1 (en) High storage capacity, fast kinetics, long cycle-life, hydrogen storage alloys
ZA200304928B (en) Medicament containing a polyamine as an active substance.
MXPA03004203A (en) Cellulosic product having high compression recovery.
BR0014213A (en) Hard caramels with improved storage stability
UA87813C2 (en) Controlled releases system containing temozolomide
AU2001269536A1 (en) Accumulator
HUP0200465A2 (en) Granulate with high content of l-carnitine oe an alkanoyl l-carnitine, particularly suitable for the production of tablets by direct compression
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
AU2001210944A1 (en) Detergent tablet
AU2003269871A1 (en) Radiosensitizer composition containing n-acetylphytosphingosine analogs and n,n-dimethyl-phytosphingosine analogs as the active ingredients
AUPR095200A0 (en) Cell production

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
WWE Wipo information: entry into national phase

Ref document number: 03019101

Country of ref document: CO

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/002013

Country of ref document: MX

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase